Reference
[Please submit your publication]
|
Kovács L, Nagy O, Pál M, Udvardy A, Popescu O, Deák P. Role of the deubiquitylating enzyme DmUsp5 in coupling ubiquitin equilibrium to development and apoptosis in Drosophila melanogaster. PLoS One (2015) 10(3) e0120875
[
PubMed ID = 25806519
]
[
RRC reference
]
Fernández-Espartero CH, Rizzo A, Fulford AD, Falo-Sanjuan J, Goutte-Gattat D, Ribeiro PS. Prp8 regulates oncogene-induced hyperplastic growth in Drosophila. Development (2018) 145(22)
[
PubMed ID = 30333215
]
[
RRC reference
]
Ohhara Y, Nakamura A, Kato Y, Yamakawa-Kobayashi K. Chaperonin TRiC/CCT supports mitotic exit and entry into endocycle in Drosophila. PLoS Genet (2019) 15(4) e1008121
[
PubMed ID = 31034473
]
[
RRC reference
]
Zhang J, Liu M, Su Y, Du J, Zhu AJ. A targeted in vivo RNAi screen reveals deubiquitinases as new regulators of Notch signaling. G3 (Bethesda) (2012) 2(12) 1563-75
[
PubMed ID = 23275879
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
0 |
0 |
8 |
NM_139516.1 |
CG12082-RA (CG12082), mRNA |
0 |
0 |
4 |
4 |
2 |
NM_135667.3 |
CG6614-RA (CG6614), mRNA |
0 |
0 |
4 |
3 |
3 |
NM_057414.3 |
CG1389-RA (tor), mRNA |
0 |
0 |
3 |
5 |
3 |
NM_132740.1 |
CG15890-RA (CG15890), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_206483.1 |
CG15890-RA (CG15890), mRNA, sub-group O CG3143-RB, transcript variant B (foxo), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_206482.1 |
CG15890-RA (CG15890), mRNA, sub-group O CG3143-RB, transcript variant B (foxo), mRNA, sub-group O CG3143-RC, transcript variant C (foxo), mRNA |
0 |
0 |
2 |
3 |
3 |
NM_142073.3 |
CG15890-RA (CG15890), mRNA, sub-group O CG3143-RB, transcript variant B (foxo), mRNA, sub-group O CG3143-RC, transcript variant C (foxo), mRNA, sub-group O CG3143-RA, transcript variant A (foxo), mRNA |
0 |
0 |
2 |
3 |
2 |
NM_136876.2 |
CG8321-RA (CG8321), mRNA |
0 |
0 |
2 |
1 |
1 |
NM_205985.1 |
CG32975-RC, transcript variant C (nAcRalpha-34E), mRNA |
0 |
0 |
2 |
1 |
1 |
NM_205986.1 |
CG32975-RB, transcript variant B (nAcRalpha-34E), mRNA |
0 |
0 |
2 |
1 |
1 |
NM_176035.2 |
CG32975-RA, transcript variant A (nAcRalpha-34E), mRNA |
0 |
0 |
1 |
4 |
6 |
NM_169264.1 |
CG9735-RA, transcript variant A (Aats-trp), mRNA |
0 |
0 |
1 |
4 |
5 |
NM_057303.4 |
CG7831-RA (ncd), mRNA |
0 |
0 |
1 |
3 |
6 |
NM_079659.2 |
CG3937-RA, transcript variant A (cher), mRNA |
0 |
0 |
1 |
3 |
6 |
NM_206502.1 |
CG3937-RD, transcript variant D (cher), mRNA |
0 |
0 |
1 |
3 |
2 |
NM_132090.2 |
CG3446-RA (CG3446), mRNA |
0 |
0 |
1 |
2 |
7 |
NM_206558.1 |
CG33340-RA (CG33340), mRNA |
0 |
0 |
1 |
2 |
6 |
NM_140571.3 |
CG5895-RA (CG5895), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_057977.3 |
CG9239-RA, transcript variant A (B4), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_165046.1 |
CG9239-RB, transcript variant B (B4), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_132328.1 |
CG17446-RA (CG17446), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_132441.1 |
CG2174-RA, transcript variant A (Myo10A), mRNA |
0 |
0 |
1 |
2 |
3 |
NM_001042804.1 |
CG2174-RB, transcript variant B (Myo10A), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_206381.1 |
CG16838-RC, transcript variant C (CG16838), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_206380.1 |
CG16838-RD, transcript variant D (CG16838), mRNA |
0 |
0 |
1 |
2 |
2 |
NM_136672.2 |
CG1688-RA (CG1688), mRNA |
0 |
0 |
0 |
6 |
3 |
NM_141308.1 |
CG12170-RA (CG12170), mRNA |
0 |
0 |
0 |
6 |
3 |
NM_132199.2 |
CG2206-RA, transcript variant A (l(1)G0193), mRNA |
0 |
0 |
0 |
5 |
11 |
NM_079205.3 |
CG7507-RA, transcript variant A (Dhc64C), mRNA |
0 |
0 |
0 |
5 |
6 |
NM_170004.1 |
CG7070-RB, transcript variant B (PyK), mRNA |
|